News

• Doximity increased 16% to $23.81 after the company reported better-than-expected quarterly results.
  
  Revenue in the fiscal 2024 second quarter ending in September increased 11% to $113.6 million from $102.2 million, net income jumped to $30.6 million from $26.3 million, and diluted earnings per share rose to 15 cents from 12 cents a year ago.
  
  The company anticipated revenue in the fiscal third quarter ending in December in the range of $127 million and $128 million and adjusted EBITDA between $61 million and $62 million.
  
  The healthcare professional company More
  
  Nov 10, 2023
• Doximity increased 16% to $23.81 after the company reported better-than-expected quarterly results.
  
  Revenue in the fiscal 2024 second quarter ending in September increased 11% to $113.6 million from $102.2 million, net income jumped to $30.6 million from $26.3 million, and diluted earnings per share rose to 15 cents from 12 cents a year ago.
  
  The company anticipated revenue in the fiscal third quarter ending in December in the range of $127 million and $128 million and adjusted EBITDA between $61 million and $62 million.
  
  The healthcare professional company updated its full-year guidance to between $460 million and $472 million and adjusted EBITDA to between $207 million and $219 million.
  
  At the time of announcing previous quarterly results, the company had estimated annual revenue between $452 million and $468 million and EBITDA between $193 million and $209 million.
  
  The company's board authorized $70 million of its own stock repurchases over the next year. Less
  
  Nov 10, 2023


• Doximity Inc declined 5.5% to $32.02 after the company reported mixed quarterly results in the fiscal fourth quarter ending in March. 
  
  Revenue in the quartet increased 18% to $111.0 million from $97.0 million and net income dropped to $30.7 million from $36.7 million and diluted earnings per share declined to 14 cents from 20 cents a year ago. 
  
  The company forecasted revenue in the fiscal first quarter ending in June between $106.5 million and $107.5 million and for the full-year between $500 million and $506 million. 
  
  The company forecasted More
  
  May 17, 2023
• Doximity Inc declined 5.5% to $32.02 after the company reported mixed quarterly results in the fiscal fourth quarter ending in March. 
  
  Revenue in the quartet increased 18% to $111.0 million from $97.0 million and net income dropped to $30.7 million from $36.7 million and diluted earnings per share declined to 14 cents from 20 cents a year ago. 
  
  The company forecasted revenue in the fiscal first quarter ending in June between $106.5 million and $107.5 million and for the full-year between $500 million and $506 million. 
  
  The company forecasted adjusted EBITDA in the June quarter between $39 million and $40.0 million and for the fiscal year 2024 between $216 million and $222 million.  Less
  
  May 17, 2023

Executive/
Director

Links

YTD

Earnings

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Outstanding Shares
(In Millions) +

Financial Statements
+

SEC Filings

Financial Ratios